TY - JOUR
T1 - Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome
AU - Nishida, Takeshi
AU - Tsuneyama, Koichi
AU - Fujimoto, Makoto
AU - Nomoto, Kazuhiro
AU - Hayashi, Shinichi
AU - Miwa, Shigeharu
AU - Nakajima, Takahiko
AU - Nakanishi, Yuko
AU - Sasaki, Yoshiyuki
AU - Suzuki, Wataru
AU - Iizuka, Seiichi
AU - Nagata, Mitsunobu
AU - Shimada, Tsutomu
AU - Aburada, Masaki
AU - Shimada, Yutaka
AU - Imura, Johji
N1 - Funding Information:
We thank Tokimasa Kumada, Hideki Hatta, and Chieko Kiya for their help and technical assistance in the experiments. We would also like to thank Yukari Inoue for her support during the preparation of this manuscript. We would like to express our appreciation to Dr Ulrich Deuschle (Phenex Pharmaceuticals AG, Germany) for his valuable advice. The project was supported in part by Grant-in Aid-for Scientific Research (B and C), Japan Society for the Promotion Science (24390181 and 21590433), Takeda Science Foundation, Japan (2010), and TSOD Mouse Research Fund.
PY - 2013/2
Y1 - 2013/2
N2 - Metabolic syndrome is a worldwide healthcare issue and a dominant risk factor for the development of incurable diseases that affect the entire body. The hepatic manifestations of this syndrome include nonalcoholic fatty liver disease (NAFLD) and its progressive variant nonalcoholic steatohepatitis (NASH). The basic pathogenesis of NAFLD/NASH remains controversial because it is difficult to clarify the disease process of NASH on the basis of metabolic syndrome alone. To determine the pathogenesis and effective treatment, an excellent animal model of NASH is required. Tsumura Suzuki obese diabetes (TSOD) male mice spontaneously develop diabetes mellitus, obesity, glucosuria, hyperglycemia, and hyperinsulinemia without any special treatments such as gene manipulation. In this study, we examined the histopathological characteristics of visceral fat and liver of 56 male TSOD mice aged 4-17 months and 9 male Tsumura Suzuki non-obesity (control) mice aged 6-12 months. In the visceral fat, enlargement of adipocytes and perivascular and pericapsular CD8-positive lymphoid aggregation were observed in 4-month-old mice. Abnormal expression of tumor necrosis factor-α, interleukin-6, and lipid peroxidation endo products was observed in macrophages. In the liver, microvesicular steatosis, hepatocellular ballooning, and Mallory bodies were observed in 4-month-old mice, with severity worsening with increasing time. These pathological findings in the liver mimic those seen in patients with NASH. Interestingly, small liver nodules with high cellularity and absence of portal tracts were frequently observed after 12 months. Most of them showed nuclear and structural atypia, and mimicked human hepatocellular carcinoma. The degree of steatosis in the non-tumor portions of the liver improved when the liver nodules developed. These findings were not observed in control mice. Here, we report that TSOD male mice spontaneously developed NAFLD without any special treatment, and that these mice are a valuable model for assessing NASH and NASH carcinogenesis owing to metabolic syndrome.
AB - Metabolic syndrome is a worldwide healthcare issue and a dominant risk factor for the development of incurable diseases that affect the entire body. The hepatic manifestations of this syndrome include nonalcoholic fatty liver disease (NAFLD) and its progressive variant nonalcoholic steatohepatitis (NASH). The basic pathogenesis of NAFLD/NASH remains controversial because it is difficult to clarify the disease process of NASH on the basis of metabolic syndrome alone. To determine the pathogenesis and effective treatment, an excellent animal model of NASH is required. Tsumura Suzuki obese diabetes (TSOD) male mice spontaneously develop diabetes mellitus, obesity, glucosuria, hyperglycemia, and hyperinsulinemia without any special treatments such as gene manipulation. In this study, we examined the histopathological characteristics of visceral fat and liver of 56 male TSOD mice aged 4-17 months and 9 male Tsumura Suzuki non-obesity (control) mice aged 6-12 months. In the visceral fat, enlargement of adipocytes and perivascular and pericapsular CD8-positive lymphoid aggregation were observed in 4-month-old mice. Abnormal expression of tumor necrosis factor-α, interleukin-6, and lipid peroxidation endo products was observed in macrophages. In the liver, microvesicular steatosis, hepatocellular ballooning, and Mallory bodies were observed in 4-month-old mice, with severity worsening with increasing time. These pathological findings in the liver mimic those seen in patients with NASH. Interestingly, small liver nodules with high cellularity and absence of portal tracts were frequently observed after 12 months. Most of them showed nuclear and structural atypia, and mimicked human hepatocellular carcinoma. The degree of steatosis in the non-tumor portions of the liver improved when the liver nodules developed. These findings were not observed in control mice. Here, we report that TSOD male mice spontaneously developed NAFLD without any special treatment, and that these mice are a valuable model for assessing NASH and NASH carcinogenesis owing to metabolic syndrome.
KW - animal model
KW - hepatocellular carcinoma
KW - inflammation
KW - nonalcoholic steatohepatitis
KW - obesity
KW - oxidative stress
KW - type-2 diabetes
UR - http://www.scopus.com/inward/record.url?scp=84873862555&partnerID=8YFLogxK
U2 - 10.1038/labinvest.2012.155
DO - 10.1038/labinvest.2012.155
M3 - 学術論文
C2 - 23212097
AN - SCOPUS:84873862555
SN - 0023-6837
VL - 93
SP - 230
EP - 241
JO - Laboratory Investigation
JF - Laboratory Investigation
IS - 2
ER -